Evidence map›Paper›PMID 37307673›Full record

ArticleJCO oncology practice2023

Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer.

Maria Alice Franzoi, Lena Degousée, Elise Martin, Patricia Miguel Semedo, Marion Aupomerol, Davide Soldato, Antonio Di Meglio, Camila Chiodi, Aude Barbier, Hajer Chaouachi and 15 more

Open access · hybridAbstract read
In one paragraph

Article in JCO oncology practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 2 countries.

Maria Alice FranzoiCancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.ORCID 0000-0002-2470-6054
Lena DegouséeBreast Oncology Unit, Gustave Roussy, Villejuif, France.
Elise MartinCancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.ORCID 0000-0001-9679-7226
Patricia Miguel SemedoHospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.ORCID 0000-0002-8984-6832
Marion AupomerolBreast Oncology Unit, Gustave Roussy, Villejuif, France.ORCID 0000-0001-5339-4507
Davide SoldatoCancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.ORCID 0000-0002-2090-3245
Antonio Di MeglioCancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.ORCID 0000-0002-0233-3189
Camila ChiodiCancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Aude BarbierCancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Hajer ChaouachiSupportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.
Nathalie RenvoiséSupportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.
Diane BoinonSupportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.ORCID 0000-0003-1365-0566
Léonor FasseSupportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.
Joana RibeiroBreast Oncology Unit, Gustave Roussy, Villejuif, France.ORCID 0000-0001-7947-672X
Jean Bernard Le-ProvostSupportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.
Johanna ArvisCancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Céline LazorthesResilience Care, Paris, France.
Mario di PalmaSupportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.ORCID 0000-0001-8639-1898
Anne de JesusPatient Committee, Gustave Roussy, Villejuif, France.
Bruno RaynardSupportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.
Arnaud PagèsBiostatistics and Epidemiology Department, Gustave Roussy, Villejuif, France.ORCID 0000-0002-2337-8693
Suzette DelalogeBreast Oncology Unit, Gustave Roussy, Villejuif, France.ORCID 0000-0003-2106-9165
Barbara PistilliBreast Oncology Unit, Gustave Roussy, Villejuif, France.ORCID 0000-0002-9184-7199
Florian ScottéSupportive Care and Patient Pathway Department, Gustave Roussy, Villejuif, France.
Ines Vaz-LuisCancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.ORCID 0000-0002-7194-2260
Institut Gustave Roussy · FRInserm · FRCentre National de la Recherche Scientifique · FRHospital de Santa Maria · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOptimal comprehensive survivorship care is insufficiently delivered. To increase patient empowerment and maximize the uptake of multidisciplinary supportive care strategies to serve all survivorship needs, we implemented a proactive survivorship care pathway for patients with early breast cancer at the end of primary treatment phase.

methodsPathway components included (1) a personalized survivorship care plan (SCP), (2) face-to-face survivorship education seminars and personalized consultation for supportive care referrals (Transition Day), (3) a mobile app delivering personalized education and self-management advice, and (4) decision aids for physicians focused on supportive care needs. A mixed-methods process evaluation was performed according to the Reach, Effectiveness, Adoption, Implementation and Maintenance framework including administrative data review, pathway experience survey (patient, physician, and organization), and focus group. The primary objective was patient-perceived satisfaction with the pathway (predefined progression criteria for pathway continuation ≥70%).

resultsOver 6 months, 321 patients were eligible for the pathway and received a SCP and 98 (30%) attended the Transition Day. Among 126 patients surveyed, 77 (66.1%) responded. 70.1% received the SCP, 51.9% attended the Transition Day, and 59.7% accessed the mobile app. 96.1% of patients were very or completely satisfied with the overall pathway, whereas perceived usefulness was 64.8% for the SCP, 90% for the Transition Day, and 65.2% for the mobile app. Pathway implementation seemed to be positively experienced by physicians and the organization.

conclusionPatients were satisfied with a proactive survivorship care pathway, and the majority reported that its components were useful in supporting their needs. This study can inform the implementation of survivorship care pathways in other centers.

Indexed as

Breast NeoplasmsCritical PathwaysFemaleHumansPatient SatisfactionSurvivorsSurvivorship

Identifiers

PMID37307673
PMCPMC10332840
OpenAlexW4380301711

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.